Lilly Presses On In China With Manufacturing Expansion In Suzhou And Partnership With Novast
This article was originally published in PharmAsia News
Executive Summary
Just two weeks after Lilly opened its diabetes R&D center in Shanghai, the company announced the opening of a second manufacturing site in Suzhou and an outsourcing manufacturing partnership with Novast in Nantong.